8/11/2011

The FDA approved Complera, an oral HIV drug containing Truvada, from Gilead Sciences, and Edurant, from Johnson & Johnson unit Tibotec. Complera is indicated for once-daily use by previously untreated patients.

Full Story:
Forbes

Related Summaries